tykhr
sign in
free sign up
Telomir Pharmaceuticals, Inc. Common Stock
Biotechnology
Healthcare
TELO
29.61 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
1.75
52 week high
7.84
high
1.81
52 week low
1.69
low
1.68
growth
-70.68 %
previous Close
1.76
P/E ratio
market cap
145 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-5.99 M
-313.44 %
eps
0.00 %
-313.70 %
eps surprise
0.00 %
net profit margin
-599073300.00 %
0.00 %
operating incoming
-6.01 M
-307.34 %
net change in cash
-1.05 M
24.53 %
cash on hand
835 K
-55.70 %
cost of revenue
6.01 M
307.34 %
top